New technology transforming vaccine development through faster viral detection

(LumaCyte) Could we finally have a faster, more objective analytical tool to rapidly measure viral infectivity for vaccine development and production? Scientists and bioengineers at Thermo Fisher Scientific and LumaCyte believe we do. This peer reviewed work will be published on Sept. 12 in the prestigious journal, Vaccine, by Elsevier, detailing how LumaCyte's RadianceTM instrument, based on Laser Force Cytology (LFC), offers researchers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news